Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TRIM29 Antikörper (AA 1-200)

TRIM29 Reaktivität: Human WB Wirt: Maus Monoclonal TRIM29-1042 unconjugated
Produktnummer ABIN6938676
  • Target Alle TRIM29 Antikörper anzeigen
    TRIM29 (Tripartite Motif Containing 29 (TRIM29))
    Bindungsspezifität
    • 21
    • 7
    • 6
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-200
    Reaktivität
    • 62
    • 9
    • 9
    • 6
    • 6
    • 5
    • 4
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    Human
    Wirt
    • 32
    • 29
    • 1
    Maus
    Klonalität
    • 35
    • 27
    Monoklonal
    Konjugat
    • 36
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser TRIM29 Antikörper ist unkonjugiert
    Applikation
    • 37
    • 22
    • 19
    • 17
    • 14
    • 8
    • 6
    • 3
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Spezifität
    It recognizes a 66 kDa protein, which is identified as Tripartite motif-containing protein 29 (TRIM29). It interacts with the intermediate filament protein vimentin, a substrate for the PKC family of protein kinases, and with hPKCI-1, an inhibitor of the PKCs. TRIM29 protein contains both zinc finger and leucine zipper motifs, suggesting that the it may form homodimers and possibly associate with DNA. High expression of TRIM29 has been reported in gastric cancer and pancreatic cancer, and correlates with enhanced tumor growth and lymph node metastasis. TRIM29 is also able to distinguish lung squamous cell carcinoma from lung adenocarcinoma with ~90 % positive accuracy, when used in a panel with TTF-1, p63, CK5/6, and Napsin-A antibodies.
    Kreuzreaktivität (Details)
    Human.
    Aufreinigung
    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
    Immunogen
    Recombinant fragment (126 Amino acid residues between aa 1-200) of human TRIM29 protein
    Klon
    TRIM29-1042
    Isotyp
    IgG2b kappa
    Top Product
    Discover our top product TRIM29 Primärantikörper
  • Applikationshinweise

    Known_Application: Western Blot (1-2 μg/mL), Optimal dilution for a specific application should be determined.

    Positive_Control: A431 cells. Tonsil or Squamous cell carcinoma.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1.0 mg/mL
    Buffer
    Prepared in 10 mM PBS, WITHOUT BSA and Azide.
    Konservierungsmittel
    Azide free
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
    Haltbarkeit
    24 months
  • Target
    TRIM29 (Tripartite Motif Containing 29 (TRIM29))
    Andere Bezeichnung
    TRIM29 (TRIM29 Produkte)
    Synonyme
    ATDC antikoerper, 1110047J21Rik antikoerper, 2810431N19Rik antikoerper, 4732461M22Rik antikoerper, AI119726 antikoerper, MGC53484 antikoerper, TRIM29 antikoerper, atdc antikoerper, tripartite motif containing 29 antikoerper, tripartite motif-containing 29 antikoerper, tripartite motif containing 29 L homeolog antikoerper, TRIM29 antikoerper, Trim29 antikoerper, trim29.L antikoerper, trim29 antikoerper
    Hintergrund
    Ataxia telangiectasia group D complementing gene (ATDC), Tripartite motif-containing protein 29 (TRIM29),TRIM29 (Lung Squamous Cell Carcinoma Marker)
    Cellular localisation: Cytoplasmic & Cell Surface
    Molekulargewicht
    66kDa
    Gen-ID
    23650, 504115
    UniProt
    Q14134
    Pathways
    p53 Signalweg, Apoptose, DNA Reparatur, Inositol Metabolic Process, Positive Regulation of Response to DNA Damage Stimulus
Sie sind hier:
Kundenservice